Uripay
৳ 270 – ৳ 300
Brand Name: Uripay
Generic Name: Flavoxate Hydrochloride BP
Therapeutic Class: Urinary Alkalizing Agent/Urinary Retention
- Additional information
- Presentation
- Description
- Indication
- Dose And Administration
- Side Effects
- Warning & Precaution
- Contraindication
- Use In Pregnancy And Lactation
- Packaging
- Drug Interaction
- Overdose
- Reviews (0)
Additional information
| STRENGTH | 100mg, 200mg |
|---|
Presentation
Uripay 100 Tablet: Each film coated tablet contains Flavoxate Hydrochloride BP 100 mg.
Uripay 200 Tablet: Each film coated tablet contains Flavoxate Hydrochloride BP 200 mg.
Therapeutic Class: Urinary Alkalizing Agent/Urinary Retention
Description
Uripay is a synthetic urinary tract spasmolytic. Flavoxate counteracts smooth muscle spasm of the urinary tract and exerts its effect directly on the muscle. It relaxes the muscles of the urinary tract.
Indication
Uripay is indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis and urethrocystitis.
Dose And Administration
Adults and children over 12 years of age: Each tablet (100 mg to 200 mg) 3 times a day. With improvement of symptoms, the dose may be reduced. Elderly patients: Should be taken careful.
Side Effects
Common: Gastrointestinal: Nausea, vomiting, dry mouth. CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness. Hematologic: Leukopenia (with is reversible upon discontinuation of the drugs.)
Rare: Cardiovascular: Tachycardia and palpitation. Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia. Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation.
Warning & Precaution
Flavoxate should be given cautiously in patients with suspected glaucoma. Patients should be informed that if drowsiness and blurred vision occur, they should not operate a motor vehicle or machinery or participate in activities where alertness is required.
Contraindication
Flavoxate is contraindicated in patients who have any of the following obstructive Conditions: Pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Use In Pregnancy And Lactation
Pregnancy Category B. This drug should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Caution should be exercised when flavoxate is administered to a nursing woman.
Packaging
Uripay 100 Tablet: Each box contains 3 X 10’s tablet in Alu-PVC blister strips.
Uripay 200 Tablet: Each box contains 2 X 10’s tablet in Alu-PVC blister strips.
Drug Interaction
a) With medicine: Increased CNS effects with other sedative agents.
b) With Food and others: Alcohol can increase the nervous system side effects of flavoxate such as dizziness, drowsiness, and difficulty concentrating.
Overdose
The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. It is not known whether flavoxate HCl is dialyzable.
Related products
-
-
Select options
- Human Division
Alken Solution
- ৳ 100 – ৳ 190
-
-
-
-
-
-
Reviews
There are no reviews yet.